Trademark Overview
On Sunday, November 17, 2024, a trademark application was filed for A AARDVARK THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the A AARDVARK THERAPEUTICS trademark a serial number of 98857689. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, May 14, 2025. This trademark is owned by AARDVARK THERAPEUTICS, INC.. The A AARDVARK THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Therapeutics and clinical programs targeting neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, and rare conditions; therapeutic compounds targeting neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, and rare conditions; therapeutic compounds for cancer treatment and management; abuse-deterrent pharmaceutical formulations
Medical and scientific research and development in the field of diagnosis and treatment of neuro-psychological disorders, autism, metabolic and inflammatory conditions, obesity and metabolic disorders, and rare conditions; providing medical and scientific research information in the fields of neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, and rare conditions; design and conduct of clinical trials for pharmaceuticals, drug development, and therapeutic applications in the fields of neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, and rare conditions